Spermidine level as a parameter in the treatment of patients with malignant melanoma
- PMID: 2580707
- DOI: 10.1007/BF00254474
Spermidine level as a parameter in the treatment of patients with malignant melanoma
Abstract
Before, during, and after 19 courses of chemotherapy given to patients with disseminated malignant melanoma plasma spermidine levels were determined with a radioimmunoassay. Baseline values were normal in 17 courses, a doubling of plasma levels following chemotherapy occurred in 13 courses. There was no relation between the occurrence of a tumor response and an increase in spermidine levels nor between hematological toxicity or digestive tract toxicity and spermidine levels.
References
MeSH terms
Substances
LinkOut - more resources
Medical